Third vaccine dose, Iss: recommended in pregnancy and lactation

The booster with the third dose of the anti-Covid vaccine is “recommended” in pregnancy and lactation. The update of the guidelines on the third dose of anti-Covid vaccine in pregnancy and lactation of the Higher Institute of Health (ISS) provides for this. “It is recommended to offer a dose of mRna vaccine, as a booster of a primary vaccination cycle in accordance with the provisions in force, to pregnant women who are in the second and third trimester and wish to be vaccinated”, he stresses. the Iss. The booster dose can be “administered at the same time as vaccinations against influenza and whooping cough recommended during pregnancy”, specifies the ISS. Read also “The recommendation takes into account the numerous and growing evidence regarding the safety of vaccination in pregnancy, both for the fetus and for the mother; the evidence relating to the greater morbidity associated with the Delta variant; its increasing circulation and the significant lowering of median age of infection in Italy – the experts recall – To date there is still little evidence relating to vaccinations performed in the first trimester, therefore women who wish to be vaccinated in this gestational period must evaluate the risks and benefits together with a healthcare professional “. “Women at greater risk of contracting Sars-CoV-2 infection because they are more exposed (such as healthcare professionals or caregivers) or at greater risk of developing serious Covid-19 disease (women with risk factors such as age over 30 years, body mass index over 30, comorbidities, citizenship of countries with high migratory pressure) remain the priority target for vaccination during pregnancy “, the ISS doctors recall. Administration “must be performed in the dosages authorized for the purpose (30 mcg in 0.3 mL for Comirnaty; 50 mcg in 0.25 mL for Spikevax), regardless of the vaccine used for the primary course, and provided that a minimum interval of at least five months (150 days) from its completion “, they specify in the update of the guidelines. For vaccination in breastfeeding, the ISS “recommends offering a dose of mRna vaccine, as a booster of a primary vaccination cycle in accordance with the provisions in force, to breastfeeding women, without any need to interrupt lactation. Administration must be performed – continues the ISS – in the dosages authorized for the purpose (30 mcg in 0.3 mL for Comirnaty; 50 mcg in 0.25 mL for Spikevax), regardless of the vaccine used for the primary cycle and provided that a minimum interval of at least five months (150 days) has elapsed from the completion of the same “.” For breastfeeding women, it should be noted that vaccination does not expose the infant to risks and allows it to take antibodies against SARS through the milk. CoV-2. The infant suckled by a vaccinated mother follows his vaccination schedule without any changes “, remarks the ISS.